Index S&P 500
P/E 6.21
EPS (ttm) 1.51
Insider Own 1.95%
Shs Outstand 1.21B
Perf Week -0.64%
Market Cap 11.24B
Forward P/E 3.35
EPS next Y 2.79
Insider Trans -0.06%
Shs Float 1.18B
Perf Month 5.04%
Income 1.83B
PEG -
EPS next Q 0.65
Inst Own 78.51%
Short Float / Ratio 2.47% / 3.23
Perf Quarter -13.16%
Sales 15.42B
P/S 0.73
EPS this Y -11.59%
Inst Trans 2.15%
Short Interest 29.10M
Perf Half Y 0.43%
Book/sh 17.09
P/B 0.55
EPS next Y -5.65%
ROA 3.76%
Target Price 11.41
Perf Year -15.05%
Cash/sh 1.16
P/C 8.08
EPS next 5Y -2.50%
ROE 9.15%
52W Range 8.74 - 12.40
Perf YTD -15.81%
Dividend 0.48
P/FCF 5.36
EPS past 5Y 5.60%
ROI 4.81%
52W High -24.43%
Beta 1.14
Dividend % 5.12%
Quick Ratio 1.06
Sales past 5Y 8.11%
Gross Margin 41.35%
52W Low 7.21%
ATR 0.21
Employees 37000
Current Ratio 1.60
Sales Q/Q -2.96%
Oper. Margin 13.43%
RSI (14) 52.97
Volatility 2.00% 2.28%
Optionable Yes
Debt/Eq 0.89
EPS Q/Q -5.60%
Profit Margin 11.88%
Rel Volume 0.82
Prev Close 9.18
Shortable Yes
LT Debt/Eq 0.83
Earnings Nov 07 AMC
Payout 28.11%
Avg Volume 9.02M
Price 9.37
Recom 2.82
SMA20 1.51%
SMA50 0.22%
SMA200 -5.36%
Volume 7,425,894
Change 2.07%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-23-23 Downgrade
BofA Securities
Neutral → Underperform
$13 → $9
Jun-23-23 Downgrade
Barclays
Equal Weight → Underweight
$11
Apr-24-23 Downgrade
Barclays
Overweight → Equal Weight
$11
Feb-17-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$16 → $14
Jan-27-23 Upgrade
Jefferies
Hold → Buy
$13 → $15
Nov-10-22 Upgrade
UBS
Sell → Neutral
$9 → $12
Nov-08-22 Upgrade
Piper Sandler
Underweight → Neutral
$10
Oct-21-22 Resumed
Jefferies
Hold
$11
Jun-14-22 Initiated
UBS
Sell
$9
May-10-22 Downgrade
Piper Sandler
Neutral → Underweight
$10
Mar-01-22 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-01-22 Downgrade
BofA Securities
Buy → Neutral
$21 → $13
Jun-15-21 Initiated
Citigroup
Neutral
$16
Apr-07-21 Resumed
RBC Capital Mkts
Outperform
$24
Mar-08-21 Downgrade
Goldman
Buy → Neutral
$20 → $15
Mar-02-21 Downgrade
JP Morgan
Overweight → Neutral
$21 → $18
Feb-26-21 Downgrade
Wolfe Research
Outperform → Peer Perform
$17
Jan-05-21 Initiated
Argus
Hold
Dec-14-20 Initiated
Bernstein
Mkt Perform
$21
Show Previous Ratings
Nov-24-23 08:16PM
Nov-22-23 06:38AM
Nov-21-23 06:00PM
05:09AM
Nov-20-23 06:30AM
03:00PM
Loading…
Nov-17-23 03:00PM
11:32AM
Nov-14-23 08:00AM
Nov-13-23 08:00AM
Nov-10-23 09:30AM
Nov-09-23 03:49AM
12:18AM
Nov-08-23 03:36PM
12:17PM
10:34AM
05:25PM
Loading…
Nov-07-23 05:25PM
04:27PM
(Associated Press Finance)
04:02PM
Nov-06-23 10:47AM
Nov-05-23 01:27AM
Oct-31-23 11:17AM
10:01AM
05:05AM
Oct-30-23 04:35PM
04:30PM
12:10PM
09:00AM
Oct-29-23 05:35PM
Oct-27-23 08:45AM
Oct-25-23 04:00PM
02:44PM
Loading…
Oct-24-23 02:44PM
11:02AM
Oct-23-23 12:52PM
09:00AM
Oct-20-23 05:00PM
Oct-18-23 08:00AM
Oct-13-23 09:15AM
Oct-10-23 09:29AM
Oct-08-23 09:45AM
08:15AM
Oct-03-23 12:28PM
Oct-02-23 04:54PM
04:31PM
(Investor's Business Daily)
03:58PM
11:33AM
Oct-01-23 06:01PM
05:16PM
05:00PM
Sep-30-23 07:58AM
Sep-28-23 10:48AM
Sep-27-23 08:00AM
08:00AM
Sep-14-23 09:18AM
Sep-12-23 04:00PM
Sep-09-23 07:20AM
Sep-07-23 07:17PM
Sep-06-23 12:33PM
12:03PM
11:30AM
Sep-05-23 10:36AM
05:00AM
Sep-01-23 08:30AM
Aug-31-23 08:45AM
Aug-30-23 09:55AM
Aug-24-23 05:00PM
Aug-23-23 12:06PM
Aug-18-23 07:45AM
Aug-16-23 11:06AM
Aug-11-23 10:00AM
08:25AM
Aug-10-23 09:30AM
06:08AM
Aug-09-23 09:37AM
07:22AM
07:07AM
Aug-08-23 09:54AM
09:42AM
Aug-07-23 10:55PM
(Thomson Reuters StreetEvents)
09:00PM
07:11PM
05:14PM
03:37PM
12:59PM
12:59PM
12:35PM
(American City Business Journals)
12:33PM
12:08PM
08:15AM
07:11AM
06:59AM
06:54AM
Aug-04-23 08:20AM
Jul-31-23 11:45AM
06:59AM
Jul-22-23 06:00AM
Jul-20-23 09:20AM
Jul-19-23 02:00PM
08:18AM
Jul-15-23 05:00PM
Jul-14-23 07:45AM
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Ni Xiangyang (Sean) President, Greater China Nov 24 Sale 9.37 14,937 139,942 64,658 Nov 24 06:00 PM Ni Xiangyang (Sean) President, Greater China Nov 23 Option Exercise 0.00 33,179 0 79,595 Nov 24 06:00 PM Ni Xiangyang (Sean) President, Greater China Mar 06 Sale 11.08 3,148 34,891 46,416 Mar 06 07:01 PM Cuneo Andrew See Remarks Mar 04 Option Exercise 0.00 6,518 0 53,460 Mar 06 07:00 PM Roman Brian Global General Counsel Mar 04 Option Exercise 0.00 17,774 0 96,585 Mar 06 07:00 PM CORNWELL W DON Director Mar 04 Option Exercise 0.00 20,313 0 42,510 Mar 06 07:01 PM MARK RICHARD A Director Mar 04 Option Exercise 0.00 20,313 0 53,478 Mar 06 07:01 PM HIGGINS MELINA E Director Mar 04 Option Exercise 0.00 20,313 0 83,381 Mar 06 07:01 PM KILTS JAMES M Director Mar 04 Option Exercise 0.00 20,313 0 98,590 Mar 06 07:01 PM van der Meer Mohr Pauline Director Mar 04 Option Exercise 0.00 20,313 0 40,267 Mar 06 07:00 PM GOETTLER MICHAEL Chief Executive Officer Mar 04 Option Exercise 0.00 107,827 0 365,119 Mar 06 07:00 PM Lyons Dillon JoEllen Director Mar 04 Option Exercise 0.00 20,313 0 59,859 Mar 06 07:01 PM COURY ROBERT J Executive Chairman Mar 04 Option Exercise 0.00 127,970 0 1,236,952 Mar 06 07:01 PM Campbell Paul See Remarks Mar 04 Option Exercise 0.00 18,515 0 113,538 Mar 06 07:01 PM KORMAN HARRY Director Mar 04 Option Exercise 0.00 20,313 0 70,951 Mar 06 07:00 PM Narula Sanjeev Chief Financial Officer Mar 04 Option Exercise 0.00 40,287 0 89,996 Mar 06 07:00 PM Mauro Anthony See Remarks Mar 04 Option Exercise 0.00 37,917 0 355,502 Mar 06 07:00 PM PARRISH MARK W Director Mar 04 Option Exercise 0.00 20,313 0 102,563 Mar 06 07:00 PM Malik Rajiv President Mar 04 Option Exercise 0.00 85,314 0 685,631 Mar 06 07:00 PM Ni Xiangyang (Sean) President, Greater China Mar 04 Option Exercise 0.00 7,835 0 49,564 Mar 06 07:01 PM Ni Xiangyang (Sean) President, Greater China Mar 03 Sale 11.18 3,093 34,579 41,729 Mar 06 07:01 PM Campbell Paul See Remarks Mar 02 Option Exercise 0.00 47,712 0 101,172 Mar 06 07:01 PM COURY ROBERT J Executive Chairman Mar 02 Option Exercise 0.00 108,739 0 1,162,429 Mar 06 07:01 PM GOETTLER MICHAEL Chief Executive Officer Mar 02 Option Exercise 0.00 91,623 0 294,432 Mar 06 07:00 PM Roman Brian Global General Counsel Mar 02 Option Exercise 0.00 14,096 0 84,567 Mar 06 07:00 PM Cuneo Andrew See Remarks Mar 02 Option Exercise 0.00 7,929 0 50,105 Mar 06 07:00 PM Ni Xiangyang (Sean) President, Greater China Mar 02 Option Exercise 0.00 7,765 0 44,822 Mar 06 07:01 PM Malik Rajiv President Mar 02 Option Exercise 0.00 322,494 0 648,123 Mar 06 07:00 PM Mauro Anthony See Remarks Mar 02 Option Exercise 0.00 148,163 0 340,490 Mar 06 07:00 PM Narula Sanjeev Chief Financial Officer Mar 02 Option Exercise 0.00 28,192 0 61,299 Mar 06 07:00 PM Ni Xiangyang (Sean) President, Greater China Feb 28 Sale 11.22 5,250 58,893 37,057 Mar 01 07:01 PM Ni Xiangyang (Sean) President, Greater China Feb 27 Option Exercise 0.00 13,142 0 42,307 Mar 01 07:01 PM GOETTLER MICHAEL Chief Executive Officer Feb 27 Option Exercise 0.00 128,728 0 257,130 Mar 01 07:04 PM Narula Sanjeev Chief Financial Officer Feb 27 Option Exercise 0.00 22,796 0 43,624 Mar 01 07:05 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite